Secondary Logo

Journal Logo

Original Article

A view of maternal mortalities in women conceiving through assisted reproductive techniques: A nation-based study of Turkey

Üstün, Yaprak Engina; Sanisoğlu, Semaa; Çınar, Mehmeta,*; Keskin, Hüseyin Leventb; Uygur, Dileka; Özcan, Ayşeb; Karaahmetoğlu, Selmab; Kabasakal, Aysunb; Çolak, Gülşenb; Keskinkılıç, Bekirb; Şencan, İrfanb

Author Information
Journal of the Chinese Medical Association: November 2018 - Volume 81 - Issue 11 - p 985-989
doi: 10.1016/j.jcma.2018.05.006

    Abstract

    1. Introduction

    Maternal mortality is a socioeconomic and cultural indicator that reflects a country's general state of health care.1 The United Nation's fifth Millennium Development Goals set targets for reducing maternal mortality by 2015.2 The maternal mortality ratio (MMR) of Turkey in the 2007–2009 period was 19.7 per 100,000 live births.3 Many maternal deaths are preventable, and a review of the underlying clinical and social risk factors is important to decrease the number of these deaths.

    Assisted reproduction techniques (ARTs) have become widely used in the treatment of human infertility. It is well known that pregnancies after ARTs have more complications than spontaneous pregnancies. With the increasing use of ARTs, the rates of both obstetrical complications, such as antenatal bleeding, multiple pregnancy, gestational hypertension, placenta previa, placental abruption, gestational diabetes mellitus, and prenatal complications (e.g., preterm delivery, low birth weight, and fetal growth restriction) increase.4,5 Although poorly understood, these medical complications may have an effect on the ART process or may be related to associated medical problems and conditions, including the subfertility status.5

    Herein, we aim to evaluate all Turkish maternal deaths in women conceiving through ARTs between January 2007 and December 2014.

    2. Methods

    This study was approved by the Zekai Tahir Burak Women Health and Research Hospital ethics committee, and the tenets of the Declaration of Helsinki were followed. After the approval, we retrospectively reviewed the national health ministry records of maternal deaths following ART pregnancies between January 2007 and December 2014. All maternal deaths following pregnancies with ARTs were identified through the National Maternal Mortality Surveillance System. We analyzed the system data encompassing an 8-year period.

    In Turkey, all of the deaths are recorded to a government software program defined as the Death Notification System (DBS). The system does not allow burial without being recorded to the DBS. Maternal deaths in Turkey are identified by the pregnancy checkbox on the death certificate. The checkbox identifies whether the woman was pregnant at the time of death, within 42 days of death, within 43 days to 1 year of death, or not pregnant in the year before death. Thus, all maternal deaths per year were recorded accurately. All medical records pertinent to the maternal death (e.g., hospital, prenatal, and specialist) and any autopsy reports are requested and reviewed by a committee at the Turkish Health Ministry, including clinicians, 4 nurses, 1 perinatologist, 3 obstetricians, 1 internal specialist, and 1 anesthetist. The committee meets to conduct the reviews weekly. Parameters set out by the World Health Organization (WHO) in the ICD-10 regarding direct and indirect causes of maternal death were used.6 Maternal death is defined as the death of a woman while pregnant or within 42 days of termination of the pregnancy, irrespective of the duration and site of the pregnancy and of any cause related to, or aggravated by, the pregnancy or its management, with the exception of accidental or incidental causes. Causes of maternal death were classified into 2 types: direct and indirect causes. Deaths resulting from obstetric complications, such as hypertension or postpartum hemorrhage, were defined as direct causes. Deaths resulting from a preexisting disease or a disease that developed during pregnancy and was not due to any of the direct obstetrical causes but was aggravated by the physiological effects of pregnancy, such as an infectious disease, neoplasm, or a circulatory system-related disease, were defined as indirect causes. The MMR was calculated as the number of maternal deaths during a given time period per 100,000 live births during the same time period.

    During the study period, there were 10,369,064 live births and 1788 maternal deaths resulting from both direct and indirect causes. We identified 28 maternal death cases in women conceiving through ART procedures.

    The age, gestational age at birth, number of antenatal visits, delivery route, time of death, and cause of death were recorded. Also, any existing delay (phase 1, 2, or 3) and preventability of maternal death were assessed. Phase 1 delay was defined as whether the patient decided to seek care; phase 2 delay was defined as the arrival at a health facility; and phase 3 delay was defined as the provision of adequate care in the clinic. Also, phase 0 was defined as unpreventable maternal deaths.7

    Information on the forms was entered into an Excel spreadsheet. Data were then transferred into a statistical package.

    3. Results

    Table 1 presents the MMR of Turkey between 2007 and 2014. The mean MMR was calculated as 17.2 per 100,000 live births in this period. The MMR of Turkey resulting from the Maternal Mortality Registration System of the Ministry of Health in 2014 was 15.2 in 100,000 live births. There was a significant reduction in the country's MMR.

    T1-9
    Table 1:
    Maternal mortality ratio of Turkey.

    A total of 28 maternal deaths following ART pregnancies are summarized in Table 2. There were 476,000 ART cycles conducted in Turkey during the 8-year study period. The live birth rate among the ART cycles was 28.5% in the same period. Therefore, we determined that total live birth count as 135,660 after ART treatment, and the maternal death rate among ART cases was calculated as 20.6 per 100,000 live births. No significant difference was observed between the ART pregnancies and overall pregnancies in terms of MMRs (20.3/100,000 vs. 17.2/100,000, p > 0.05). The mean ± SD age was 32.9 ± 5.4 years, and the median (minimum–maximum) duration of gestation at the time of maternal death was 31 weeks (7–38 weeks). Regarding the causes of maternal death following ART pregnancies, hypertensive disorders and cardiovascular disease were the 2 leading causes of maternal deaths (Table 3). Approximately 54% of maternal deaths following ARTs were attributed to indirect causes (e.g., pulmonary embolism, cardiovascular disease, fulminate hepatic failure, and intracranial hemorrhage).

    T2-9
    Table 2:
    Causes of maternal death in women conceived by in vitro fertilization.
    T3-9
    Table 3:
    Maternal death in ART pregnancies in the Turkey, 2007–2014.

    Table 3 depicts the demographic and clinical characteristics of cases. Twelve women (40%) were aged >35 years. Nine women (32%) were pregnant with twins. Of the women, 24 women (88%) had 4 or more antenatal visits, and 19 women (68%) had a cesarean delivery. Two (7%) had perimortem cesarean sections, and 22 women (78%) were lost during puerperium (see Table 4).

    T4-9
    Table 4:
    Demographic and clinical characteristics of cases.

    The number of unpreventable maternal deaths was 19 (68%). Among maternal deaths, 9 (36%) were classified as preventable. Two deaths (7%) were due to the patients’ lack of knowledge and attitude (phase 1 delay). Providing and receiving timely care after reaching the referral site was a problem among 7 (25%) women (phase 3 delay). Phase 3 delay was seen in 1 (3%) patient due to inappropriate management of severe preeclampsia (see Fig. 1).

    F1-9
    Fig. 1.:
    The cause of maternal death by autopsy in Turkey from 2007 to 2014 in patients conceived with ART.

    4. Discussion

    Maternal death is an important worldwide health problem, especially for developing countries. Because the averseness to high-risk pregnancies has increased, complications and delays in the management of these complications threaten mothers’ lives. Furthermore, due to the widespread use of ARTs, obstetric and neonatal morbidities have risen. In this descriptive retrospective study, we aimed to evaluate the demographic characteristics of maternal death of those conceiving through ARTs. During the study period, 28 maternal deaths were conceived through ARTs among 1788 maternal deaths. The mean age of the cases was 33.2 ± 5.6, and the median gestational age at death was 31 weeks of gestation. There were 13 direct causes and 15 indirect causes of death, and the most common cause of death was cardiovascular disease.

    The prevalence of hypertensive disorders is increasing in ART pregnancies. Say et al. combined 417 data points from 115 countries and studied 62,378 maternal deaths.2 They reported a 14% ratio of maternal deaths caused by hypertensive disorders. Shevell et al.8 found a 2.7-fold increase in the incidence of preeclampsia in 554 ART pregnancies. Allen and Wilson9 reported a 2-fold increase in hypertensive disorders in women with ART pregnancies compared with spontaneous conceptions. In Turkey, in a 7-year period, there were 8 maternal deaths due to hypertensive disorders of pregnancy in women conceiving through ARTs. In 1 patient, phase 3 delay was seen due to inappropriate management of severe preeclampsia. We found the rate of maternal deaths caused by hypertension to be 28%. Among these deaths, 3 were caused by HELLP syndrome. Women conceiving through ARTs require closer antenatal surveillance for hypertensive disorders of pregnancy. The increase in the maternal mortality rate due to hypertensive disorders following ARTs was caused by the increase in hypertensive disorders in ART pregnancies. We recommend that all maternity units should have clear guidelines for the management of severe preeclampsia and that treatment protocols should include intravenous antihypertensive agents. The examination of hypertensive diseases in all ART pregnancies has been a limitation of our study.

    Braat et al.10 evaluated all deaths following ARTs in the Netherlands in a 24-year period and found that the major causes of death directly related to ARTs were sepsis and ovarian hyperstimulation syndrome. In a study by Venn et al.,11 the overall mortality rate in ART patients in Australia was significantly less than that in the general female population. Regarding the causes of maternal death, pulmonary embolus and cardiovascular disease were the 2 leading causes of maternal death, followed by hypertensive disorders, in Turkey in the study period. During the study period, 2 deaths were caused by septic abortion. These cases were twin pregnancies that ended in deaths after abortion of the first fetuses at the second trimester. In twin pregnancies, follow-up of the second fetuses after abortion of the first fetuses increased the maternal morbidity and mortality. Roman et al. reported on 19 delayed-interval deliveries and concluded that the procedure is associated with a significant risk of serious maternal morbidity.12 It is known that multiple pregnancy rate and abortion rate increases with ART pregnancies. When an abortion occurs with a twin ART pregnancy, the expectation and fear of the other baby's survival increases, and this puts pressure on physicians. Thus, a “healthy decision-making ability” is weakened. In both cases, phase 3 delay occurred and sepsis-induced disseminated intravascular coagulation was the major cause of death. Patients with delayed-interval delivery should be counseled and followed up carefully regarding the risks and benefits of the procedure, including the >30% risk of major maternal morbidity ranging from hemorrhage to septic shock.

    Recently, Hansen et al.13 carried out a national register-based cohort study to find the risk of venous thrombosis in pregnancies after ARTs and revealed a significantly increased venous thromboembolism (VTE) risk throughout pregnancy and the post-partum period in ART pregnancies. An excess VTE risk was found to be most prominent during the first trimester and the first 6 weeks postpartum. In another study, the incidence of first-trimester VTE in relation to ARTs was found to be 0.2%, representing a 10-fold increase compared with the background population.14 Pulmonary embolism occurred in 4 cases who conceived through ARTs in Turkey. Failure of consideration for thromboprophylaxis with low molecular weight heparin was noted in 2 patients. Royal College advises that women with an ART pregnancy and 3 other risk factors should be considered for thromboprophylaxis with low molecular weight heparin starting in the first trimester.15

    Shevell et al.8 found a 2.7-fold increase in the incidence of preeclampsia in this group of women. Allen and Wilson9 published a review and revealed a 2-fold increase in hypertensive disorders of pregnancy in women with ART pregnancies compared with spontaneous conceptions. In Turkey, in an 8-year period, there were 7 maternal deaths due to hypertensive disorders of pregnancy in women conceiving through ARTs. Phase 3 delay was seen in 1 patient due to inappropriate management of severe preeclampsia. Women conceiving through ARTs require closer antenatal surveillance for hypertensive disorders of pregnancy.

    In conclusion, because of increased risk factors, women conceiving through ARTs should undergo a careful assessment of risk factors for pulmonary embolism and cardiovascular diseases and require closer antenatal surveillance for hypertensive disorders of pregnancy.

    References

    1. Creanga AA, Berg CJ, Ko JY, Farr SL, Tong VT, Bruce FC, et al. Maternal mortality and morbidity in the United States: where are we now? J Womens Health (Larchmt). 2014;23:3-9.
    2. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:323-333.
    3. Engin-Üstün Y, Çelen Ş, Özcan A, Sanisoğlu S, Karaahmetoğlu S, Gül R, et al. Maternal mortality from cardiac disease in Turkey: a population-based study. J Matern Fetal Neonatal Med. 2012;25:2451-2453.
    4. Halliday J. Outcomes of IVF conceptions: are they different? Best Pract Res Clin Obstet Gynaecol. 2007;21:67-81.
    5. Mukhopadhaya N, Arulkumaran S. Reproductive outcomes after in-vitro fertilization. Curr Opin Obstet Gynecol. 2007;19:113-119.
    6. World Health Organization & Unicef., 2014. Trends in maternal mortality: 1990 to 2013: estimates by WHO, UNICEF, UNFPA, the World bank and the united nations population division, World Health Organization, Geneva, Switzerland.
    7. Thaddeus S, Maine D. Too far to walk: maternal mortality in context. Soc Sci Med. 1994;38:1091-1110.
    8. Shevell T, Malone FD, Vidaver J, Porter TF, Luthy DA, Comstock CH, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol. 2005;106:1039-1045.
    9. Allen VM, Wilson RD, Cheung A, Blight C, Désilets VA, Gagnon A, et al. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can. 2006;28:220-233.
    10. Braat DDM, Schutte JM, Bernardus RE, Mooij TM, Van Leeuwen FE. Maternal death related to IVF in The Netherlands 1984–2008. Hum Reprod. 2010;25:1782-1786.
    11. Venn A, Hemminki E, Watson L, Bruinsma F, Healy D. Mortality in a cohort of IVF patients. Hum Reprod. 2001;16:2691-2696.
    12. Roman AS, Fishman S, Fox N, Klauser C, Saltzman D, Rebarber A. Maternal and neonatal outcomes after delayed-interval delivery of multifetal pregnancies. Am J Perinatol. 2011;28:091.
    13. Hansen AT, Schmidt M, Horváth–Puhó E, Pedersen L, Rothman KJ, Hvas AM, et al. Preconception venous thromboembolism and placenta-mediated pregnancy complications. J Thromb Haemost. 2015;13:1635-1641.
    14. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97:95-100.
    15. Royal college of obstetricians and gynecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top Guideline No. 37a. April 2015.
    Keywords:

    Cause of death; Hypertensive disorders; In vitro fertilization; Maternal death; Perinatal outcome; Pulmonary embolism

    © 2018 by Lippincott Williams & Wilkins, Inc.